Literature DB >> 3530154

Cardiac transplantation. Emerging from an experiment to a service.

B P Griffith, R L Hardesty, A Trento, R L Kormos, H T Bahnson.   

Abstract

Cardiac transplantation was resumed at the University Health Center of Pittsburgh in 1980 after a hiatus of 12 years. Prior to April 15, 1986, 270 hearts had been transplanted. Participants have been forced to reorder personal, professional, and institutional commitments to adapt to new demands of pre- and post-operative care and to develop flexibility in the operative scheduling of routine cardiac surgical cases. The actuarial survival has been 78, 69, and 64% at 1, 2, and 3 years. Much has been learned about evolving immunosuppression based on cyclosporine and of the allogenic response. An increasing proportion of recipients are mortally ill (54%), and for these urgent patients the wait for a donor organ continues to lengthen. The cardiac surgeon performing transplantations will need to grow with allied developments in xenotransplantation and mechanical cardiac support devices in order to keep pace with his evolving specialty.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530154      PMCID: PMC1251282          DOI: 10.1097/00000658-198609000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients.

Authors:  A Zeevi; J Fung; T R Zerbe; C Kaufman; B S Rabin; B P Griffith; R L Hardesty; R J Duquesnoy
Journal:  Transplantation       Date:  1986-05       Impact factor: 4.939

Review 2.  Cardiac homotransplantation.

Authors:  W A Baumgartner; B A Reitz; P E Oyer; E B Stinson; N E Shumway
Journal:  Curr Probl Surg       Date:  1979-09       Impact factor: 1.909

3.  Mortally ill patients and excellent survival following cardiac transplantation.

Authors:  R L Hardesty; B P Griffith; A Trento; M E Thompson; P F Ferson; H T Bahnson
Journal:  Ann Thorac Surg       Date:  1986-02       Impact factor: 4.330

4.  Targeted blood levels of cyclosporin for cardiac transplantation.

Authors:  B P Griffith; R L Hardesty; A Trento; A Lee; H T Bahnson
Journal:  J Thorac Cardiovasc Surg       Date:  1984-12       Impact factor: 5.209

5.  Development and organization of a multiple organ transplantation program.

Authors:  H T Bahnson; T E Starzl; T R Hakala; R L Hardesty; B P Griffith; S Iwatsuki
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

6.  Clinical use of the total artificial heart.

Authors:  W C DeVries; J L Anderson; L D Joyce; F L Anderson; E H Hammond; R K Jarvik; W J Kolff
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

7.  Powerful but limited immunosuppression for cardiac transplantation with cyclosporins and low-dose steroid.

Authors:  B P Griffith; R L Hardesty; H T Bahnson
Journal:  J Thorac Cardiovasc Surg       Date:  1984-01       Impact factor: 5.209

8.  Baboon-to-human cardiac xenotransplantation in a neonate.

Authors:  L L Bailey; S L Nehlsen-Cannarella; W Concepcion; W B Jolley
Journal:  JAMA       Date:  1985-12-20       Impact factor: 56.272

9.  Management of cyclosporine toxicity by reduced dosage and azathioprine.

Authors:  B P Griffith; R L Hardesty; A Lee; A Trento; M E Thompson; A P Shapiro; H T Bahnson
Journal:  J Heart Transplant       Date:  1985 Jul-Aug

10.  Cytoimmunological monitoring in acute rejection and viral, bacterial or fungal infection following transplantation.

Authors:  W Ertel; H Reichenspurner; C Lersch; C Hammer; M Plahl; M Lehmann; B M Kemkes; G Osterholzer; B Reble; B Reichart
Journal:  J Heart Transplant       Date:  1985 Jul-Aug
  10 in total
  1 in total

1.  Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy.

Authors:  I L Kron; T L Flanagan; L H Blackbourne; R A Schroeder; S P Nolan
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.